Urovant Sciences Ltd. UROV
— —
Day range unavailable
52-week range unavailable
Latest period ending Mar 31, 2020 · select a line to chart its full history
Income statement
| Fiscal year | FY 2020 Mar 31, 2020 | FY 2019 Mar 31, 2019 | FY 2018 Mar 31, 2018 | FY 2017 Mar 31, 2017 |
|---|---|---|---|---|
| -138.97M | -110.78M | -37.00M | -27.06M | |
| -146.75M | -111.35M | -37.07M | -26.97M | |
| -4.82 | -4.43 | -2.16 | -10.10 |
Balance sheet
| Fiscal year | FY 2020 Mar 31, 2020 | FY 2019 Mar 31, 2019 | FY 2018 Mar 31, 2018 | FY 2017 Mar 31, 2017 |
|---|---|---|---|---|
| 51.66M | 85.60M | 7.19M | 4.77M | |
| 63.30M | 100.12M | 12.98M | 4.78M | |
| 121.30M | 25.35M | 5.91M | 866.40K | |
| 90.69M | 13.53M | 0 | 0 | |
| -58.01M | 74.77M | 7.07M | 3.91M |
Cash flow
| Fiscal year | FY 2020 Mar 31, 2020 | FY 2019 Mar 31, 2019 | FY 2018 Mar 31, 2018 | FY 2017 Mar 31, 2017 |
|---|---|---|---|---|
| -102.08M | -109.04M | -34.09M | -25.26M | |
| -769.00K | -593.00K | -522.00K | 0 | |
| 68.94M | 188.63M | 37.03M | 30.02M | |
| -769.00K | -593.00K | -522.00K | 0 | |
| -33.92M | 79.00M | 2.43M | 4.77M |